Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles
Author(s) -
Peter Humaidan,
Inge Van Vaerenbergh,
C. Bourgain,
Birgit Alsbjerg,
Christophe Blockeel,
Frans Schuit,
Leentje Van Lommel,
Paul Devroey,
Human M. Fatemi
Publication year - 2012
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/des279
Subject(s) - luteal phase , oocyte , antagonist , andrology , endocrinology , medicine , gonadotropin releasing hormone antagonist , hormone antagonist , biology , receptor , gonadotropin releasing hormone , follicular phase , luteinizing hormone , hormone , microbiology and biotechnology , embryo
Do differences in endometrial gene expression exist after ovarian stimulation with four different regimens of triggering final oocyte maturation and luteal phase support in the same patient?
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom